Umbilical Stem Cells are Adult Stem Cells taken from the umbilical cord. Their function is to be a repair system for the human body because they can divide themselves without limit to replenish other cells as long as the person is still alive. When a mother gives birth to a healthy baby, she donates umbilical cord blood that carries the progenitor’s cells; these Umbilical Cord Stem Cells have been used for so many years now in adults and children to treat diseases such as cancer and blood disorders, without having any secondary diseases (effects).
About the Umbilical Stem Cells therapy, most children receive the Stem Cells via a subcutaneous injection right into the tissues adjacent to the umbilicus, so cells can migrate from that area and start circulating in few hours or days. In teenagers and adults, the Stem Cells are given by IV drip. Blood may be reinjected so the number of growth factors given with the Stem Cells increase. The first changes usually appear by the third or fourth week after the treatment is done, and the main changes come during the first 180 days after the treatment. In rare occasions, some patients discover new improvements after a year or more, but on most people they start to diminish after six months.
The first two weeks after the treatment are considered very important because it is when the Stem Cells start to create safe homes to grow and multiply into more healthy Stem Cells. That is why patients need to avoid anything that can kill off the Stem Cells (by following a diet given by the doctors), and instead promote healthy Stem Cell growth.
The advantages of the umbilical cord blood are that it does not need a perfect human leukocyte antigen tissue match and can be used allogenically.
The umbilical cord blood contains hematopoietic Stem Cells that are used to generate red blood cells and cells of the immune system. These types of Stem Cells are also used to treat blood disorders such as Leukemia, Anemia and immune system conditions. Though these stem cells had been used mostly in children’s treatments, nowadays, they have gained more use in adults that need chemotherapy treatments.
The Mesenchymal Stromal Cells are another type of cells that can also be taken from the umbilical cord blood and they grow into the bone, cartilage, and other tissues. A lot of research has been made about these types of cells in order to discover all their benefits for patients.
Umbilical cord blood is donated from healthy mothers who give birth to full term, normal, healthy babies, it is then screened for major communicable diseases according to the American Association of Blood Banks standards. Only Type O, Universal Donor type is accepted. Blood that passes the test at this level is then sent to a laboratory where skilled technicians use special technology to separate CD34+/CD133+ cells, CD44- cells, and other subtypes. These progenitor cells are then expanded in a medium that is free from any animal products. After peak expansion is reached, the stem cells are frozen in liquid nitrogen and stored. As for safety concerns, Umbilical cord stem cells have been used for over 18 years in both adults and children in the treatment of cancer and blood disorders, with no reports of secondary diseases or cancers from the use of the cord blood.
Most commonly vials containing 5 million hUCSCs are utilized.
The decision to have or not to have stem cell therapies is difficult for all involved. The decision as to what type of cells to use, how to give the cells, what tests need to be done before hand and what treatments need to be done before and after the treatment all vary from case to case. Such questions are best answered by doctors after copies of the patient’s medical records and enrollment forms have been received and reviewed.
Most infants and small children are given the stem cells via a subcutaneous injection into the tissues adjacent to the umbilicus. Older children and adults are typically given stem cells by IV drip. Blood may be drawn and reinjected to increase the number of growth factors given with the stem cells. Some neurological patients receive hUCSCs by direct catheter implant into the damaged areas of the brain, a procedure performed by an interventional radiologist and operating room team.
Research has shown that injecting cells subcutaneously near the umbilicus produces notable results. It appears the cells migrate from the injection site and enter the circulation over a period of hours and perhaps days. Since an IV approach is not always easily done on some patients, especially infants and small children, the “subQ” approach is routinely employed on these patients. In older patients, direct introduction of the cells into the circulation via IV is used. There are some neurological conditions for which a direct infusion of cells into the circulatory system is deemed the best approach to treating the patient. The use of a subcutaneous IV or combination route is decided based on clinical study and past stem cell patient responses.
It is reported that the first changes appear by the 3rd to 4th week after treatment and major changes are seen during the first 180 days following treatment. They may then plateau and diminish over time, although some patients report seeing new improvements more than one year following a single treatment.
There is no way the cells could engraft, differentiate and begin “doing their thing” in a matter of minutes or hours. It is felt that the initial results are attributable to growth factors present in the stem cell medium. Also, the cells themselves may stimulate the body to create growth factors and other compounds that foster cell repair and replacement.
First, the umbilical cord stem cells begin to produce a specific growth factor almost immediately after injection which has the power to rescue neurons from a lack of oxygen, associated with conditions that include a stroke or traumatic brain injury. This glial derived growth factor activity can rescue up to 60-70% of dying neurons if administered soon after the injury. In later stages and in younger patients such as those suffering from cerebral palsy, one type of stem cell (CD34+) has a tendency to produce “white matter cells”. These cells make up the “wiring” that connects one neuron to the next and to the muscles of the body. When you look at a cross section of the brain, the white matter makes up about 60% of the brain’s inner volume. The gray matter is the neurons which are spread over the surface of the brain. While the CD34+ stem cells have been reported to promote some neurons in addition to the glial white matter, the primitive progenitor cells (AC133+) more readily assist with neuronal growth. Besides rescuing dying tissues by the action of glial derived neuron factors, the stem cells may also save cells by a process called “ cell fusion”. In this method, the stem cells seek out sick and dying cells and melt their body into the dying cell body. This combination cell then has the vitality of the stem cell and its cell nucleus. Such fusion is more often in brain cells that have hundreds of connections with other cells.
Many studies have shown that stem cells “home” in on specific chemical signals given off by injured, damaged or diseased tissues or organs.
When these signals are weak they require intervention to increase their numbers. There are several ways to amplify these chemical signals. Pre-stem cell treatment programs, comprehensive 5 to 35 day outpatient programs, are recommended in such cases.
One of the difficulties in getting hUCSCs into the brain lies in the blood brain barrier which slows or blocks entry of many things into the central nervous system including stem cells. Children and adult patients with Multiple Sclerosis and many other neurological diseases have “leaky” blood brain barriers due to the inflammation. Fortunately, a formula has been developed which temporarily opens up the blood brain barrier long enough for a great many stem cells to get into the brain.
In general, think in terms of what you should eat if you were a young woman who has just become pregnant.
Serotonin generating foods: Squash, pumpkin, turnips, and celery.
Calcium rich foods: Salmon, sardines, green leafy vegetables, collards, filberts, kale, kelp, mustard greens, prunes, turnip greens, and watercress.
Magnesium rich foods: Avocados, brewer’s yeast, dulse, green leafy vegetables, salmon, and watercress.
Potassium rich foods: Avocados, brewer’s yeast, dulse, raisins, and winter squash.
B complex rich foods: Folic acid is in green leafy vegetables, asparagus, and spinach. Vitamin B6 is in poultry, fish oil, vegetables, sunflower seeds. Vitamin B12 is in poultry, fish and fish oil.
Seaweeds such as wakame and kombu contain sulfated fucoidans which support bone marrow stem cells production.
Avocados also contain tyrosine, a mood elevator. The processing of tyrosine in nervous tissue is associated with the growth and guidance of nerve pathways.
Ginseng for two months can assist with both stem cell growth and stem cell differentiation into specialized cells.
Ginkgo Biloba also assists with stem cell growth and differentiation. However do not take this if you are taking other medications.
DHA (docosahexaenoic acid) rich fish and seafood. This omega 3 fatty acid plays a role in nerve cell growth, cognition and also modulates inflammatory responses.
Eat foods containing lots of Vitamin A. Sources of Vitamin A include: Cod liver oil, fish oil, beet greens, watercress, kale, pumpkin, spinach, winter squash, and leafy lettuce.
Vitamin D from 20 minutes exposure to moderate sunlight stimulates BDNF, a neural growth factor that supports the growth of new neurons. BDNF also supports the pancreas and insulin producing pancreatic cells.
Supplement with antioxidants. Among the more potent antioxidants are Glutathione, Coenzyme Q10, N-acetyl cysteine, alpha lipoic acid, and vitamin A, C, and E.